There might be an association between obesity with incidence of stroke among type 2 diabetic patients… Diabetes mellitus and obesity are the most common conditions that increase the risk of stroke in the general population. However, not many studies focused on the association between obesity and cardiovascular disease risk among …
Read More »Monthly Archives: March 2015
Lessen Cravings for Carbohydrates by Taking a Short Walk
Overweight individuals who were asked to walk on a treadmill for 15 minutes had lower cravings for sugary snacks than those who did not exercise, Austrian researchers reported in the journal PLOS ONE. European Journal of Endocrinology, March 2015
Read More »Increased Diabetes Risk with Antibiotic Use
Taking at least two courses of prescribed antibiotics was associated with a higher risk of developing type 2 diabetes, according to a new study. The likelihood of getting diabetes increased by 8% after receiving two to five courses of penicillin. For patients who took two to five courses of quinolones, …
Read More »Diabetes Patients Face Higher Health Cost and Reduced Life Span
A study in Diabetes Care found fewer life years and greater health care expenses linked to diabetes. For individuals with diabetes, the predicted life expectancy had an inverted U-shape for most BMI classifications, with overweight individuals having the highest life years lost. Higher lifelong health costs were seen in whites and …
Read More »Preventing Type 2 Diabetes Tool Kit
The Centers for Disease Control and Prevention (CDC) and the American Medical Association (AMA) have created a toolkit that health care teams can use as a guide to Screen, Test and Act Today (STAT) by referring patients to in-person or online diabetes prevention programs. You can download a complete …
Read More »Eylea (aflibercept)
FDA Approves Aflibercept for Diabetic Retinopathy in Patients with Diabetic Macular Oedema. The US Food and Drug Administration (FDA) expanded the approved use for aflibercept (Eylea) injection to treat diabetic retinopathy in patients with diabetic macular oedema (DME). Aflibercept is administered by a physician as an injection into the …
Read More »Letter from the Editor, #774
It is time to get out your wallets and take out the big bills that you have hiding in the back. Why do you need to do this? Because the cost of poor diabetes care is growing larger every day. For years we have known that patients with diabetes cost more …
Read More »Editor’s Note, DCMS #233
About a year ago one of my pharmacist colleagues called me and was complaining about his blood glucose levels. At the age of 37 he had developed diabetes and was placed on metformin. His glucose improved and he went on a wellness program. After three months he had not lost …
Read More »Insulin Resistance – A Survival Mechanism Gone Awry, Part 1
With this week’s Homerun Slides, we start a short new series on Insulin Resistance put together by Dr. Stanley Schwartz. We begin with a quick overview of the traditional view of the natural history of diabetes as compared to Dr. Schwartz’s newer beta-cell centric model…. To download the complete set …
Read More »Practical Diabetes Care, 3rd Ed., Excerpt #8: Pharmacological Treatment of Hyperglycemia Part 1 of 2
David Levy, MD, FRCP Introduction The pharmacological management of blood glucose in type 2 diabetes remains the most contentious area of diabetes management, and although until relatively recently in the USA the only agents to treat blood glucose were insulin and sulphonylureas, this limited repertoire in no way inhibited the controversy, …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.